Bod Australia (ASX:BOD) - CEO, Jo Patterson
CEO, Jo Patterson
Source: Jo Patterson
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness
  • More than 2000 leading retailers such as Coles, Priceline and Chemist Warehouse will receive these products
  • This launch marks the first hemp-based range for Swisse in Australia
  • The range is primarily made-up of skincare products, but soft gel caps containing hemp seed oil will also be launched
  • Bod’s share price is up a steady 21.4 per cent and shares are trading for 17 cents each

Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness.

More than 2000 stores will receive these products and they will initially be available in leading retailers such as Coles, Priceline, and Chemist Warehouse.

“Launching nine products with such as recognised and trusted brand in Swisse is game-changing for Bod,” CEO Jo Patterson said.

“We anticipate considerable consumer uptake once stock is available for purchase. We look forward to providing regular updates to shareholders as sales build,” she added.

Following a partnership that Bod secured with Swisse’s parent company, Health and Happiness Group, in 2019, this launch marks the first of the Swisse hemp-based range in Australia.

The range is primarily made-up of skincare products, but soft gel caps containing hemp seed oil will also be launched.

Initial interest from the large retail groups has already been encouraging.

“Swisse’s Hemp product rollout is a strategic move for the brand as we focus on offering innovative wellness solutions that respond to consumer shifts and growing demand,” Swisse Managing Director Nick Mann commented.

“We are preparing our business for the legalisation of CBD in Australia, so we can take advantage of the market with product innovation in partnership with Bod,” he added.

Swisse will undertake the sales and marketing campaigns, as well as in-store promotions.

To broaden its footprint and progress into the international market, Bod and Health and Happiness will continue working together to create new hemp-based products.

Bod’s share price is up a steady 21.4 per cent and shares are trading for 17 cents each at 2:38 pm AEDT.

BDA by the numbers
More From The Market Online

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…